THC Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
THC Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • THC Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending April 30, 2024 was $105K, a 10.9% increase year-over-year.
  • THC Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending April 30, 2024 was -$563K, a 30337% decline year-over-year.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$387K, a 74.5% increase from 2022.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$1.52M, a 19.4% increase from 2021.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.89M, a 319% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$387K +$1.13M +74.5% Aug 1, 2022 Jul 31, 2023 10-K 2024-02-26
2022 -$1.52M +$367K +19.4% Aug 1, 2021 Jul 31, 2022 10-K 2024-02-26
2021 -$1.89M -$1.44M -319% Aug 1, 2020 Jul 31, 2021 10-K 2022-11-25
2020 -$450K +$22.9M +98.1% Feb 1, 2020 Jan 31, 2021 10-Q 2021-03-29
2019 -$23.3M -$17.2M -280% Aug 1, 2018 Jul 31, 2019 10-K 2020-11-04
2018 -$6.14M Aug 1, 2017 Jul 31, 2018 10-K/A 2019-11-18
2012 -$242K -$217K -875% Aug 1, 2011 Jul 31, 2012 10-K 2012-11-13
2011 -$24.8K +$13.1K +34.6% Aug 1, 2010 Jul 31, 2011 10-K 2012-11-13
2010 -$37.9K Aug 1, 2009 Jul 31, 2010 10-K 2012-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.